Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 433,638 | 545,861 | 519,098 | 417,349 | 406,238 |
| Marketable Securities | 270,593 | 302,269 | 303,771 | 382,097 | 372,767 |
| Receivables | 68,638 | 54,257 | 47,650 | 44,427 | 43,507 |
| Inventories | 27,799 | 28,338 | 16,989 | 10,446 | 9,493 |
| Income taxes - deferred | 97,914 | 102,758 | 101,723 | 92,851 | 87,767 |
| TOTAL | $924,057 | $1,060,413 | $1,012,238 | $975,034 | $954,341 |
| Non-Current Assets | |||||
| PPE Net | 99,109 | 94,097 | 95,486 | 100,880 | 98,292 |
| Investments And Advances | 367,727 | 190,837 | 222,664 | 249,633 | 246,022 |
| Intangibles | 333,576 | 331,599 | 328,175 | 331,811 | 336,463 |
| Other Non-Current Assets | 35,662 | 34,826 | 44,623 | 42,102 | 41,325 |
| TOTAL | $836,074 | $651,359 | $690,948 | $724,426 | $722,102 |
| Total Assets | $1,760,131 | $1,711,772 | $1,703,186 | $1,699,460 | $1,676,443 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,675 | 1,647 | 1,648 |
| Accounts payable and accrued liabilities | 11,183 | 3,606 | 13,284 | 10,678 | 10,396 |
| Accrued Expenses | 110,928 | 144,608 | 126,775 | 109,601 | 111,694 |
| TOTAL | $144,330 | $165,756 | $171,616 | $163,705 | $181,911 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 4,470 | 4,880 | 5,407 |
| Deferred Revenues | 8,065 | 9,647 | 12,041 | 17,290 | 28,294 |
| Other Non-Current Liabilities | 29,489 | 28,699 | 29,080 | 32,049 | 31,662 |
| TOTAL | $43,949 | $51,337 | $58,463 | $61,364 | $61,195 |
| Total Liabilities | $188,279 | $217,093 | $230,079 | $225,069 | $243,106 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 112,049 | 111,862 | 112,729 | 113,439 | 114,041 |
| Common Shares | 112 | 112 | 113 | 113 | 114 |
| Retained earnings | 1,222,309 | 1,135,922 | 1,070,911 | 1,007,459 | 921,561 |
| Other shareholders' equity | 29,186 | 28,743 | 26,842 | 27,491 | 29,157 |
| TOTAL | $1,571,852 | $1,494,679 | $1,473,107 | $1,474,391 | $1,433,337 |
| Total Liabilities And Equity | $1,760,131 | $1,711,772 | $1,703,186 | $1,699,460 | $1,676,443 |